Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-31 @ 2:03 PM
Study NCT ID:
NCT01649856
Status:
COMPLETED
Last Update Posted:
2017-10-11
First Post:
2012-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-23
First Submit QC Date:
None
Study First Post Date:
2012-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-15
Results First Submit QC Date:
None
Results First Post Date:
2016-02-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-11
Last Update Post Date:
2017-10-11
Last Update Post Date Type:
ACTUAL